PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1967 November; 60(11 Pt 1): 1184–1186.
PMCID: PMC1902105

Immunity in Malignant Disease [Abridged]

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (433K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • BLACK MM, OPLER SR, SPEER FD. Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes. Surg Gynecol Obstet. 1955 May;100(5):543–551. [PubMed]
  • BLACK MM, SPEER FD. Sinus histiocytosis of lymph nodes in cancer. Surg Gynecol Obstet. 1958 Feb;106(2):163–175. [PubMed]
  • BRENT L, MEDAWAR PB. NATURE OF THE NORMAL LYMPHOCYTE TRANSFER REACTION. Nature. 1964 Oct 3;204:90–91. [PubMed]
  • Everson TC. Spontaneous regression of cancer. Ann N Y Acad Sci. 1964 Apr 2;114(2):721–735. [PubMed]
  • COLE WH, EVERSON TC. Spontaneous regression of cancer: preliminary report. Ann Surg. 1956 Sep;144(3):366–383. [PubMed]
  • FAIRLEY GH, MATTHIAS JQ. Cortisone and skin sensitivity to tuberculin in reticuloses. Br Med J. 1960 Aug 6;2(5196):433–436. [PMC free article] [PubMed]
  • GREENWOOD R, SMELLIE H, BARR M, CUNLIFFE AC. Circulating antibodies in sarcoidosis. Br Med J. 1958 Jun 14;1(5084):1388–1391. [PMC free article] [PubMed]
  • Hughes LE, Mackay WD. Suppression of the tuberculin response in malignant disease. Br Med J. 1965 Dec 4;2(5474):1346–1348. [PMC free article] [PubMed]
  • LAMB D, PILNEY F, KELLY WD, GOOD RA. A comparative study of the incidence of anergy in patients with carcinoma, leukemia, hodgkin's disease and other lymphomas. J Immunol. 1962 Oct;89:555–558. [PubMed]
  • LEVIN AG, CUSTODIO DB, MANDEL EE, SOUTHAM CM. REJECTION OF CANCER HOMOTRANSPLANTS BY PATIENTS WITH DEBILITATING NON-NEOPLASTIC DISEASES. Ann N Y Acad Sci. 1964 Nov 30;120:410–423. [PubMed]
  • LUKES RJ. HODGKIN'S DISEASE. PROGNOSIS AND RELATIONSHIP OF HISTOLOGIC FEATURES TO CLINICAL STAGE. JAMA. 1964 Dec 7;190:914–915. [PubMed]
  • LYTTON B, HUGHES LE, FULTHORPE AJ. CIRCULATING ANTIBODY RESPONSE IN MALIGNANT DISEASE. Lancet. 1964 Jan 11;1(7324):69–71. [PubMed]
  • MARTIN DC, RUBINI M, ROSEN VJ. CADAVERIC RENAL HOMOTRANSPLANTATION WITH INADVERTENT TRANSPLANTATION OF CARCINOMA. JAMA. 1965 May 31;192:752–754. [PubMed]
  • Nadler SH, Moore GE. Clinical immunologic study of malignant disease: response to tumor transplants and transfer of leukocytes. Ann Surg. 1966 Sep;164(3):482–490. [PubMed]
  • SCANLON EF, HAWKINS RA, FOX WW, SMITH WS. FATAL HOMOTRANSPLANTED MELANOMA: A CASE REPORT. Cancer. 1965 Jun;18:782–789. [PubMed]
  • SMITHERS DW. Spontaneous regression of tumours. Clin Radiol. 1962 Apr;13:132–137. [PubMed]
  • Southam CM. Evidence of immunological reactions to autochthonous cancer in man. Eur J Cancer. 1965 Nov;1(3):173–181. [PubMed]
  • MOORE AE, RHOADS CP, SOUTHAM CM. Homotransplantation of human cell lines. Science. 1957 Jan 25;125(3239):158–160. [PubMed]
  • WOODRUFF MF, NOLAN B. PRELIMINARY OBSERVATIONS ON TREATMENT OF ADVANCED CANCER BY INJECTION OF ALLOGENEIC SPLEEN CELLS. Lancet. 1963 Aug 31;2(7305):426–429. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press